Company achieves positive proof of concept in Phase IIa study of its lead product candidate, Bria-IMT, in advanced breast cancer patients Efficacy data comparable to that of other approved breast cancer therapies in a similar stage of development Combination study with immune checkpoint inhibitors in the works, enrollment already open BriaCell Therapeutics Corp. (OTCQB: BCTXF) […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.